Status:

COMPLETED

Inflammatory Genetic Polymorphism and Acute Lung Injury After Cardiac Surgery

Lead Sponsor:

Changhai Hospital

Conditions:

Acute Lung Injury

Eligibility:

All Genders

18+ years

Brief Summary

Acute lung injury is a common complication of cardiac surgery with cardiopulmonary bypass, and it is significantly related to prolonged postoperative recovery, hospital stays and medical cost. Current...

Eligibility Criteria

Inclusion

  • Chinese Han unrelated population
  • adult patients
  • undergoing elective cardiac surgery with CPB

Exclusion

  • malignant tumor
  • autoimmune disease, immunodeficiency or immunosuppressive therapy
  • chronic renal disease (glomerular filtration rate \< 60ml/(min•1.73m2)) or liver dysfunction (Child Pugh classification\>A)
  • COPD, tuberculosis or other chronic pulmonary diseases
  • anemia with hemoglobin lower than 90mmHg
  • bleeding disorders
  • postoperative pericardial tamponade requiring re-operation
  • postoperative low cardiac output syndrome or acute pulmonary edema after left cardiac failure.

Key Trial Info

Start Date :

May 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2009

Estimated Enrollment :

107 Patients enrolled

Trial Details

Trial ID

NCT00826072

Start Date

May 1 2008

End Date

January 1 2009

Last Update

May 3 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Changhai Hospital, Second Military Medical University

Shanghai, China, 200433